466 related articles for article (PubMed ID: 2530590)
1. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
Przegaliński E; Budziszewska B; Warchoł-Kania A; Błaszczyńska E
Pharmacol Biochem Behav; 1989 Jun; 33(2):329-34. PubMed ID: 2530590
[TBL] [Abstract][Full Text] [Related]
2. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
3. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Tricklebank MD; Neill J; Kidd EJ; Fozard JR
Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
[TBL] [Abstract][Full Text] [Related]
4. The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(DI-n-propylamino)-tetralin, is antagonized by NAN-190 in the rat.
Przegaliński E; Ismaiel AM; Chojnacka-Wójcik E; Budziszewska B; Tatarczyńska E; Błaszczyńska E
Neuropharmacology; 1990 Jun; 29(6):521-6. PubMed ID: 2143565
[TBL] [Abstract][Full Text] [Related]
5. Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors.
Hutson PH; Dourish CT; Curzon G
Eur J Pharmacol; 1988 Jun; 150(3):361-6. PubMed ID: 2970974
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation.
Koenig JI; Gudelsky GA; Meltzer HY
Eur J Pharmacol; 1987 May; 137(1):1-8. PubMed ID: 2956114
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
Chaouloff F; Jeanrenaud B
J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
[TBL] [Abstract][Full Text] [Related]
8. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
[TBL] [Abstract][Full Text] [Related]
10. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat.
Deckert V; Chaouloff F; Richer C; Elghozi JL
Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG
Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.
Fozard JR; Mir AK; Middlemiss DN
J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400
[TBL] [Abstract][Full Text] [Related]
13. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
Yamada J; Sugimoto Y; Horisaka K
Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
[TBL] [Abstract][Full Text] [Related]
14. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists.
Fuller RW; Snoddy HD
Neuroendocrinology; 1990 Aug; 52(2):206-11. PubMed ID: 2148812
[TBL] [Abstract][Full Text] [Related]
15. Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat.
Chaouloff F; Baudrie V; Laude D
Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):381-4. PubMed ID: 1970616
[TBL] [Abstract][Full Text] [Related]
16. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
17. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat.
Gradin K; Pettersson A; Hedner T; Persson B
J Neural Transm; 1985; 62(3-4):305-19. PubMed ID: 3161997
[TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).
Glennon RA
Pharmacol Biochem Behav; 1986 Jul; 25(1):135-9. PubMed ID: 2944129
[TBL] [Abstract][Full Text] [Related]
19. Apparent hyperalgesic action of the 5-HT1A agonist, 8-OH-DPAT, in the rat reflects induction of spontaneous tail-flicks.
Millan MJ; Bervoets K; Colpaert FC
Neurosci Lett; 1989 Dec; 107(1-3):227-32. PubMed ID: 2533334
[TBL] [Abstract][Full Text] [Related]
20. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
